Yanggu Huatai

Shandong Yanggu Huatai Chemical is a leading global manufacturer of rubber chemicals that has recently expanded its operations into the life sciences and pharmaceutical sectors. Through the strategic acquisition of Shandong Boao Bio-pharmaceutical, the company has transitioned into a provider of high-end pharmaceutical intermediates and CDMO (Contract Development and Manufacturing Organization) services. The company leverages its advanced chemical synthesis and large-scale manufacturing capabilities to produce critical components for various therapeutic categories, including cardiovascular and anti-infective drugs. Headquartered in Shandong, China, Yanggu Huatai is publicly traded on the Shenzhen Stock Exchange and continues to diversify its portfolio toward high-value healthcare applications.